Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use
Personalized dendritic cell- (DC-) based vaccination has proven to be safe and effective as second-line therapy against various cancer types. In terms of overall survival, there is still room for improvement of DC-based therapies, including the development of more immunostimulatory DC vaccines. In t...
Main Authors: | J. M. J. Van den Bergh, E. L. J. M. Smits, M. Versteven, H. De Reu, Z. N. Berneman, V. F. I. Van Tendeloo, E. Lion |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2017/1975902 |
Similar Items
-
Transprésences.
by: Jacques Lévy
Published: (2003-12-01) -
Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner.
by: Sébastien Anguille, et al.
Published: (2015-01-01) -
Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion
by: Heleen H. Van Acker, et al.
Published: (2018-04-01) -
Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties
by: Berneman Zwi N, et al.
Published: (2009-12-01) -
Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells
by: Heleen H. Van Acker, et al.
Published: (2016-09-01)